SomnoMed Ltd (OTCPK:SOMNF)
$ 0.1653 0 (0%) Market Cap: 62.07 Mil Enterprise Value: 56.16 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 48/100

Full Year 2023 Somnomed Ltd Earnings Call Transcript

Aug 31, 2023 / 06:30AM GMT
Release Date Price: $0.5216
Operator

Thank you for standing by, and welcome to the SomnoMed Limited FY '23 Full Year Results and Capital Raising Conference Call. I would now like to turn the conference over to Mr. Neil Verdal-Austin, CEO and Managing Director. Please go ahead.

Neil Verdal;Austin
SomnoMed Limited - Global CEO, MD & Director

Thank you very much, and good afternoon to you all, and thanks for attending this webinar conference call to cover our release made this morning to cover both the FY of '23 results and our announcement of an accelerated rights issue and placement to raise $15.5 million. Moving on to Slide 2. This really restates our very clear vision and mission. The vision is patient-centric and our mission is with the help of all industry players and partners to advance the treatment of oral appliances in the world of obstructive sleep apnea.

Slide 3 simply just covers our agenda for this call and presentation. So on to Slide 5, the financial highlights for FY '23. We achieved revenues of $83.6 million, up 15%, just on our revised revenue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot